Products - Heart failure | Topic | NICE

Showing 6 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Rivaroxaban for treating chronic heart failure [ID1462]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac death
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Pelacarsen for reducing the risk of cardiovascular events in people with established cardiovascular disease and high lipoprotein (a) [ID6559]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Enlicitide decanoate for treating hyperlipidaemia in people at risk of an atherosclerotic cardiovascular disease event [ID6656]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease [TSID12347]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC